Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Epinephrine in Pediatric Asthma Exacerbation
NCT05667727Phase 4Completed
- Sponsor
- Oman Medical Specialty Board
- Start
- Oct 2023
- Primary completion
- Jun 2025
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of epinephrine in asthma, sponsored by Oman Medical Specialty Board. Started Oct 2023; status: completed.
02
Drugs
epinephrine
03
Conditions
asthma
Beyond the preview
Go deeper on NCT05667727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05667727.